Representing the complexity of disease with the power to decode it

The Euretos Disease Atlas

Discover data-driven insights into the pathophysiology of disease through anatomical maps spanning 110 organs, 2,500 tissues and 3,500 cell types (scRNA profiles), curated for 30,000 diseases and phenotypes — powered by curated FAIR literature and data

Expand pathophysiological disease insights — fast

Uncover disease mechanisms, targets, biomarkers, and drug interactions within full anatomical and molecular context — independently and without bioinformatics support.

Expand pathophysiological disease insights — fast

Uncover disease mechanisms, targets, biomarkers, and drug interactions within full anatomical and molecular context — independently and without bioinformatics support.
Contact Us

Decode Disease Complexity

The Disease Atlas empowers researchers to identify disease-implicated cell types, uncover key disease drivers, and highlight promising targets or markers with comprehensive, evidence-based profiles

Navigate curated anatomical maps

Navigate detailed anatomical maps (incl. 3,500 scRNA profiles) curated for 30,000 diseases and phenotypes

Identify key cell types

Identify cell types most strongly linked to the disease by the associations of their genes

Review cell type disease associations

Create cell-type–level gene sets linked to disease through literature, annotations, dysregulation, and gene variants

Discover underlying disease drivers

Analyze the disease-associated gene sets to reveal key biological drivers of the disease

Select target or marker candidates

Choose potential targets or markers linked to major disease drivers using multiple key criteria

Review targets or markers in detail

Examine selected candidates in comprehensive dossiers covering all relevant aspects

Don’t just find your target or marker, understand it

Access unique, comprehensive target and marker dossiers providing full pathophysiological insight into location, biological role, and therapeutic potential within a specific disease

Anatomical Expression

Explore marker and target activity through differential expression and disease-linked dysregulation across organs, tissues and cell types

Biological Function

Understand roles in pathways, regulatory networks, cellular and metabolic interactions, including cell–cell interactions, co-expression and transcriptional control

Therapeutic Relevance

Assess efficacy, safety and marker suitability through relevant phenotypes, gene variants and clinical associations, alongside drug MoA and bioavailability

Powered by curated, FAIR data and literature

The Disease Atlas is powered by one of the world's largest collections of literature, patents, experimental, clinical & real-world patient data, including 3500 unique scRNA profiles — integrated into a vast, FAIR biological knowledge graph

Empowering translational researchers

The Euretos Disease Atlas empowers translational researchers to take a pathophysiological approach to disease biology — without requiring bioinformatics skills or data science expertise

Unique disease insight through cellular, tissue, and molecular context
Advanced analysis tools with no coding or bioinformatics expertise required
Drastically reduce time spent searching through data, studies, and literature
Interpret results in relation to disease mechanisms and biological relevance

Proven Real-World Results

We have one of the strongest track records in data-driven translational research as our platform and services have contributed to approved drugs and active clinical trials in oncology, Sjogren's disease, Ulcerative Colitis, NASH and epilepsy with 5 different biopharma clients
SVG Graphic

 
tevalogo
"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."
 
Dr. Dana Bar-On - Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva  Pharmaceuticals. 
 

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors shape disease processes to generate and refine hypotheses grounded in full biological context
SVG Graphic

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors shape disease processes to generate and refine hypotheses grounded in full biological context
SVG illustration
Get Started
SVG Graphic

Identify and prioritize novel therapeutic targets

Discover biologically relevant targets by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types.

Identify and prioritize novel therapeutic targets

Discover biologically relevant targets by evaluating expression patterns, pathway roles, and interactions within disease-specific tissues and cell types.
SVG Graphic
Contact Us

Evaluate target relevance and actionability

Review key characteristics of candidate targets — gene variants, dysregulation, druggability, and clinical associations — linked to their anatomical context and relevant disease drivers
SVG Graphic

Evaluate target relevance and actionability

Review key characteristics of candidate targets — gene variants, dysregulation, druggability, and clinical associations — linked to their anatomical context and relevant disease drivers
SVG illustration
Get Started
SVG Graphic

Discover markers linked to disease mechanisms

Discover molecular markers associated with key disease drivers by analyzing expression patterns, variants, dysregulation, and their bioavailability and metabolic interactions across relevant cell types and anatomical contexts

Discover markers linked to disease mechanisms

Discover molecular markers associated with key disease drivers by analyzing expression patterns, variants, dysregulation, and their bioavailability and metabolic interactions across relevant cell types and anatomical contexts
SVG Graphic
Contact Us

Rapidly create thorough, evidence-backed scientific briefs

Easily find well-organized information supported by publications and data on genes, diseases, mechanisms and treatments to support clear and reliable scientific communication
SVG Graphic

Rapidly create thorough, evidence-backed scientific briefs

Easily find well-organized information supported by publications and data on genes, diseases, mechanisms and treatments to support clear and reliable scientific communication
SVG illustration
Get Started
Client review

Target Discovery

"We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general queries."

Tau Benned-Jensen
Senior Research Scientist, H. Lundbeck A/S
Client review

Indication selection

“In this project, we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data-driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.”

Large European Pharma
Global Head
Client review

Target Assessment

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."

Dr. Dana Bar-On
Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals
Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target discovery meetings."

Large European Biotech
Director Target Discovery
Client review

Indication Selection

"We find that the Euretos group was very easy to work and communicate with. The professional staff at Euretos did a great job extending their platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen
Project Manager, Projects & Portfolio department, H. Lundbeck A/S
Client review

Target Assessment

"We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also, the team is well engaged, and had a very good understanding in the background of the project and our research question"

Large Japanese Pharma
Principal Scientist

Data-driven disease insights